Despite being inert and nontoxic, implanted biomaterials often trigger adve
rse foreign body reactions such as inflammation, fibrosis, infection, and t
hrombosis. With regard to the inflammatory responses to biomaterial implant
s, it was previously found that a crucial precedent event was the spontaneo
us adsorption and denaturation of fibrinogen on implant surfaces. It was fu
rther found that interactions between the phagocyte integrin Mac-1 (CD11b/C
D18) and one short sequence within the fibrinogen D domain (gamma 190-202;
P1) at least partially explained phagocyte accumulation on implant surfaces
. However, the reason that adsorbed fibrinogen is proinflammatory-while sol
uble fibrinogen clearly is not-remained obscure. In this study, therefore,
the question of how fibrinogen is converted to a proinflammatory state when
adsorbed to biomaterial surfaces is investigated. In soluble fibrinogen, t
he 13 amino acid P1 sequence was found to be hidden. However, the adsorptio
n and denaturation of fibrinogen on the surfaces of commonly used biomateri
als lead to the exposure of P1 and a second neo-epitope, gamma 377-395 (P2)
, which also interacts with Mac-1 and is similarly occult in the soluble pr
otein. The extent of biomaterial-mediated PI and P2 exposure appears direct
ly related to the severity of inflammatory responses to a test panel of bio
materials. Finally, thrombin-mediated conversion of fibrinogen to fibrin al
so exposes both P1 and P2 epitopes. These observations may help explain bot
h the inflammation caused by many types of implanted biomaterials and that
which occurs naturally following thrombotic events.